Medical Xpress December 3, 2021
Deborah Fuller, The Conversation

If the omicron variant of the coronavirus is different enough from the original variant, it’s possible that existing vaccines won’t be as effective as they have been. If so, it’s likely that companies will need to update their vaccines to better fight omicron. Deborah Fuller is a microbiologist who has been studying mRNA and DNA vaccines for over two decades. Here she explains why vaccines might need to be updated and what that process would look like.

1. Why might vaccines need to be updated?

Basically, it’s a question of whether a virus has changed enough so that antibodies created by the original vaccine are no longer able to recognize and fend off the new mutated .

Coronaviruses use

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Healthcare System, Patient / Consumer, Pharma / Biotech, Provider, Public Health / COVID
AI Ushers in HPC Revival Says TACC’s Dan Stanzione
Ozempic And Other Weight Loss Drugs Will Only Work With Digital Health
Boehringer signs $1.3B deal with RNA biotech Ochre Bio to team up against MASH
Bristol Myers taps startup to boost cell therapy production
With $380M deal, Bristol Myers Squibb ups the ante with cell therapy manufacturer Cellares

Share This Article